James Cancer Hospital and Solove Research Institute — Columbus, Ohio

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Columbus →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of James Cancer Hospital and Solove Research Institute, compiled from the ClinicalTrials.gov public registry.

236

Registered studies

64

Active

37

Recruiting now

136

Completed

28

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Advanced Solid Tumor · Neoplasm Metastasis · Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Recently updated registry entries

NCT06890598 — Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With… (Recruiting)
NCT06073821 — Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax… (Active Not Recruiting)
NCT04973605 — A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.